Debate: High risk myeloma: Should it be treated differently? – No

In this presentation from “Great Debates and Updates in Hematologic Malignancies 2016”, Dr. Ruben Niesvizky argues that high risk myeloma should not be treated differently.

A continuing education program is offered as a supplement to this webcast at the following location:
http://elc.imedex.com/ELC/Activity-Search.aspx?search=7204

© 2016 Imedex, LLC.